News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sorin Group S.p.A. Announces Third Quarter 2009 Results: Continuous Improvement in Profitability and Cash-Flow
October 29, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MILAN--(BUSINESS WIRE)--Third Quarter 2009 highlights: * Consolidated revenues at € 162.1 million, up 6.2%* (8.4% at actual exchange rates) versus Q3 08;
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Drug pricing
Novo, Lilly Shares Drop as Trump Promises $150 Ozempic
October 17, 2025
·
3 min read
·
Annalee Armstrong
Layoff Tracker
Cuts Continue as Novo Restructuring Moves Forward
October 16, 2025
·
72 min read
·
BioSpace Editorial Staff
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
October 16, 2025
·
2 min read
·
Tristan Manalac
Funding
Veradermics Gets $150M Series C To Advance Hair Regrowth Pill
October 16, 2025
·
2 min read
·
Tristan Manalac
